Paul Robbins
About Paul Robbins
Paul Robbins serves as the Vice President and Head of Translational Medicine at Instil Bio. He has extensive experience in the pharmaceutical industry, having held significant roles at MedImmune, Prolexys Pharmaceuticals, Pfizer, and Stanford University.
Current Role at Instil Bio
Paul Robbins serves as the Vice President and Head of Translational Medicine at Instil Bio. He has held this position since 2021. In this role, he is responsible for overseeing the development and implementation of translational strategies that bridge the gap between laboratory research and clinical application, focusing on advancing therapeutic options in oncology.
Previous Experience at Pfizer
Prior to his current role, Paul Robbins worked at Pfizer as Senior Director of Translational Oncology from 2015 to 2021. His responsibilities included leading initiatives that aimed to translate scientific discoveries into effective cancer therapies. This position was based in La Jolla, California.
Career at Prolexys Pharmaceuticals
Paul Robbins held the position of Director of Cancer Pharmacology and Cell Biology at Prolexys Pharmaceuticals from 2002 to 2010. During his eight years at the company, he contributed to the development of cancer treatments through his expertise in pharmacology and cell biology, operating out of Palo Alto, California.
Academic Background and Research
Paul Robbins completed his Ph.D. in Molecular Microbiology, Immunology, and Virology at the University of Southern California from 1991 to 1996. He also conducted post-doctoral research at Stanford University from 1996 to 1999, followed by a role as a Senior Research Scientist at Stanford from 1999 to 2002. His academic background laid the foundation for his extensive career in translational medicine and oncology.
Experience at MedImmune
From 2010 to 2012, Paul Robbins worked at MedImmune as a Senior Scientist. In this role, he focused on advancing biopharmaceutical development, contributing to projects aimed at improving therapeutic outcomes in various disease areas.